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HDAC7, a Thymus-Specific Class II
Histone Deacetylase, Regulates Nur77
Transcription and TCR-Mediated Apoptosis
tively, irrespective of the transcriptional activity of the
promoter. This observation has led to the model that
MEF2D influences Nur77 promoter activity by selectively
recruiting transcriptional corepressors or coactivators.
In unstimulated T lymphocytes, DNA-bound MEF2D
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is associated with Cabin 1, a calcineurin-interacting re-2 Department of Pathology and
pressor protein (Youn et al., 1999). Cabin-1 mediates3 Department of Medicine
the recruitment of HDAC1 and HDAC2, which lead toUniversity of California, San Francisco
the relative deacetylation of the Nur77 promoter.San Francisco, California 94141
Cabin-1 also competes with p300 and ERK5 for MEF2D
binding and prevents the recruitment of critical coactiva-
tor proteins (Kasler et al., 2000; Youn et al., 1999, 2000a,Summary
2000b; Youn and Liu, 2000). Interestingly, a mutant
mouse strain expressing a truncated Cabin-1 lackingWe report that HDAC7, a class II histone deacetylase,
the MEF2 binding domain showed normal thymocyteis highly expressed in CD4CD8 double-positive thy-
development and apoptosis (Esau et al., 2001), sug-mocytes. HDAC7 inhibits the expression of Nur77, an
gesting that other factors, besides Cabin-1, participateorphan receptor involved in apoptosis and negative
in the repression of Nur77 by MEF2D.selection, via the transcription factor MEF2D. HDAC7
Posttranslational modifications of nucleosomal his-is exported from the nucleus during T cell receptor acti-
tones, in particular acetylation, are emerging as a criticalvation, leading to Nur77 expression. A triple HDAC7 mu-
mechanism in the transcriptional regulation of genes bytant (S155A, S318A, S448A) is not exported from the
chromatin (Strahl and Allis, 2000). The global level ofnucleus in response to TCR activation and suppresses
histone acetylation is regulated by the antagonistic ac-TCR-mediated apoptosis. Conversely, a fusion of
tivities of histone acetyltransferases (HATs) and histoneHDAC7 to the transcriptional activator VP16 activates
deacetylases (HDACs).Nur77 expression. Inhibition of HDAC7 expression by
Mammalian HDACs fall into three distinct classesRNA interference causes increased apoptosis in re-
based on their homology to yeast proteins. Class Isponse to TCR activation. These observations define
HDACs are homologous to the RPD3, and class II HDACsHDAC7 as a regulator of Nur77 and apoptosis in devel-
are related to HDA1, while class III HDACs are homolo-oping thymocytes.
gous to SIR2.
The class IIa HDACs, HDAC4, 5, 7, and 9, share a
Introduction number of structural and functional features (reviewed in
Fischle et al., 2001b; Khochbin et al., 2001). All possess a
During T cell development in the thymus, lymphocytes conserved C-terminal catalytic domain and interact with
undergo a series of selection events. These selection MEF2 proteins via a 17 amino acid motif. This interaction
processes are dependent on signals delivered by the leads to the recruitment of class IIa HDACs to select
T cell receptor (TCR) after interaction with complexes promoters where MEF2 is bound. The repressive activity
consisting of self-peptide and major histocompatibility of class II HDACs is also controlled by nucleocytoplas-
complex (MHC). Most T cells in the thymus die by a mic shuttling and by their association with the intracellu-
process called “death by neglect” because they do not lar 14-3-3 proteins in a signal-specific manner (Dressel
express a functional TCR. In contrast, T cells expressing et al., 2001; Grozinger and Schreiber, 2000; Kao et al.,
receptors that strongly interact with self-peptide-MHC 2001; Zhou et al., 2001). Phosphorylation of conserved
complexes are eliminated by negative selection. A mi- residues in the N-terminal regions of HDAC4, 5, 7, and
nority of T cells expressing a functional TCR undergoes 9 (McKinsey et al., 2000a) leads to recognition by 14-
positive selection and further differentiation into mature 3-3 proteins, to disruption of the class II HDAC-MEF2D
T cells. A central unanswered question of T cell selection complexes, and to a conformational change leading to
is which signals emanating from the TCR complex lead nuclear export (McKinsey et al., 2001b). The functional
to either maturation during positive selection or to cell relevance of these findings has been elegantly illustrated
death during negative selection. in muscle development (reviewed by McKinsey et al.,
The orphan steroid nuclear receptor Nur77, an imme- 2001a; Wang et al., 2000).
diate-early gene responsive to TCR activation (Woronicz Here, we show that HDAC7, a class II HDAC, is ex-
et al., 1994), has been implicated in negative selection. pressed at high levels in CD4CD8double-positive thy-
Overexpression of Nur77 in vivo resulted in massive mocytes. HDAC7 represses the expression of Nur77 by
apoptosis, whereas overexpression of a dominant-neg- interacting with MEF2D in the nucleus and plays an
ative mutant inhibited TCR-mediated cell death (Calnan important role in the regulation of Nur77 expression and
et al., 1995; Liu et al., 1994; Woronicz et al., 1994). Tran- apoptosis in response to T cell activation.
scriptional activation of Nur77 by TCR activation is de-
pendent on two MEF2 sites in the Nur77 promoter (Mar- Results
tin et al., 1994; McKinsey et al., 2002; Woronicz et al.,
1995). MEF2D binds to the Nur77 promoter constitu- High HDAC7 Expression in Human Thymus
Analysis of human tissues by Northern blot with a human
HDAC7 probe showed a major transcript (4.4 kb) and a*Correspondence: everdin@gladstone.ucsf.edu
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Figure 1. Human HDAC7 Is Highly Expressed
in Double-Positive Thymocytes
(A) A multiple human tissue Northern blot
(Clontech) was probed with a human HDAC7
32P-radiolabeled cDNA probe. The same
membrane was hybridized with a probe cor-
responding to human GAPDH cDNA. Molecu-
lar size markers are indicated on the right.
(B) Real-time PCR was used to assess ex-
pression levels of HDAC4, HDAC5, and
HDAC7 in thymus and skeletal muscle. Ex-
pression levels are shown relative to a stan-
dard curve established from dilutions of plas-
mid DNA corresponding to each cDNA.
(C) Thymic and spleen sections were hybrid-
ized with a sense or an antisense RNA corre-
sponding to HDAC7. After incubation, slides
were developed and counterstained with nu-
clear fast red. The locations of the cortical
(C) and medullar (M) regions of the thymus
are indicated.
(D) Thymocytes were sorted based on sur-
face expression of CD3, CD4, and CD8 into
triple-negative (TN), double-positive (DP),
and single-positive (SP4 and SP8). Expres-
sion of class II HDACs was assessed in each
subset by real-time RT-PCR and normalized
to GAPDH expression. Class II HDAC mRNA
abundance for HDAC4 (white bars), HDAC5
(gray bars), and HDAC7 (black bars) is plotted
relative to mRNA levels in triple-negative thy-
mocytes (TN).
minor transcript (6.0 kb) in human thymus (Figure 1A). thymus showed highest levels of HDAC7 mRNA (data
not shown).Dot blot analysis of more than 40 different human tissues
confirmed that samples corresponding to adult and fetal Comparative analysis of relative expression levels of
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Figure 2. Regulation of Nur77 Transcription
by Histone Acetylation
(A) DO11.10 cells were treated with 400 nM
TSA, and expression of Nur77 was analyzed
over time by Northern blot. The same blot was
hybridized with a GAPDH probe as a control.
(B) Total cellular extracts from DO11.10 cells
treated with TSA were analyzed by Western
blotting with an anti-Nur77 antibody. The
same extracts were analyzed with an antise-
rum for actin as control.
(C) DO11.10 cells were activated with PMA/
ionomycin for 0, 1, 2, and 4 hr. Nuclear lysates
were incubated with an antibody against
acetylated histone H3. Immunoprecipitated
DNA was amplified by PCR with specific
primers for the Nur77 promoter. Results are
represented as histogram of the relative en-
richment (immunoprecipitated/input) in DNA
associated with acetylated histone H3 rela-
tive to untreated cells.
(D) Cells transfected with HDAC7-GFP were
activated with PMA/ionomycin. Subcellular
localization of HDAC7 was followed with real-
time immunofluorescence microscopy after 0,
15, and 30 min, and 1, 2 and 4 hr of treatment.
HDAC7, HDAC4, and HDAC5 by real-time polymerase population, expression of HDAC7 was higher in the more
mature CD3med/high subpopulations. In contrast, HDAC4chain reaction (PCR) showed that HDAC7 was signifi-
cantly more abundant than HDAC4 and HDAC5 in human and HDAC5 expression was moderately downregulated
during the DP stage (Figure 1D). These observationsthymus (Figure 1B). The opposite was observed in skele-
tal muscle where HDAC7 levels were below the detec- demonstrate the selective upregulation of HDAC7 ex-
pression in DP thymocytes.tion limit while HDAC4 and HDAC5 were readily de-
tected.
We used in situ hybridization with HDAC7 sense and Transcriptional Activity of Nur77 Is Regulated
by Histone Acetylationantisense RNA probe to determine the precise location
of HDAC7 expression within the thymus. Cells of Since class II HDACs and members of the MEF2 family
interact functionally in muscle development, we hypoth-lymphoid morphology containing high levels of HDAC7
transcripts were abundant in the cortical region of the esized that HDAC7 could interact with MEF2D to modu-
late Nur77 promoter activity in developing thymocytes.thymus (Figure 1C). No signal was detected with the
sense probe on thymic sections or with either probe on First, we assessed the role of histone acetylation on the
transcriptional activity of the Nur77 promoter. A T cellspleen samples (Figure 1C).
To determine the expression pattern of HDAC7 during hybridoma cell line (DO11.10) was treated with an HDAC
inhibitor, trichostatin A (TSA), and expression of Nur77thymocyte maturation, we sorted human primary thymo-
cytes by flow cytometry based on the expression of was assessed by Northern blot analysis. Nur77 mRNA
was induced in a time-dependent manner after additiondifferentiation markers CD3, CD4, and CD8. The relative
abundance of HDAC4, HDAC5, and HDAC7 mRNAs was of TSA to the culture medium (Figure 2A). Similar results
were obtained by Western blot analysis using a Nur77-assessed by real-time PCR in each population. Low
levels of HDAC7 mRNA were observed in immature tri- specific antiserum (Figure 2B). These data suggest that
the Nur77 promoter is suppressed under basal condi-ple-negative thymocytes (TN, CD3CD4CD8) (Figure
1D). HDAC7 expression was highly and transiently in- tions by the activity of an HDAC.
To assess directly the levels of histone acetylation increased during the CD4CD8 double-positive (DP)
stage and returned to lower levels in mature single- the Nur77 promoter during TCR activation, we per-
formed chromatin immunoprecipitation (ChIP) experi-positive T cells (SP4 or SP8). Within the DP thymocytes
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Figure 3. HDAC7 Represses Nur77 Promoter Activity
(A) Total cellular lysates were prepared from polyclonal DO11.10 cells stably expressing FLAG-tagged versions of wild-type HDAC7, HDAC7
H656A, HDAC7 H657A, or pCDNA3.1 (Mock); cells were treated with PMA/ionomycin for 1.5 hr. Cell lysates were analyzed by Western blotting
with antisera for Nur77, FLAG, and actin.
(B) D011.10 cells were transfected with the pNur77-Luc reporter construct and increasing amounts of HDAC7 expression vector. Luciferase
activity was measured in cells treated with PMA/ionomycin for 4 hr () and in untreated cells (). Results are from three independent
experiments each in triplicate. The activity of the Nur77 promoter is expressed relative to its activity after PMA/ionomycin treatment in mock-
transfected cells.
(C) Polyclonal cell lines expressing HDAC7 or the empty vector (Mock) were stimulated with PMA/ionomycin. Surface expression of CD69
and CD25 was measured by flow cytometry before (dotted line) and 2 hr (CD69) or 8 hr (CD25) after treatment (solid line). Western blot analysis
of the same cells for Nur77 expression confirms that HDAC7 expression leads to a suppression of Nur77 induction.
ments. DO11.10 cells were activated with phorbol myris- HDAC7 Suppresses Induction of Nur77
by TCR Signalingtate acetate (PMA) and ionomycin, a treatment that
mimics signaling by the TCR-CD3 complex. Nur77 pro- To determine whether HDAC7 can suppress the tran-
scriptional activity of the endogenous Nur77 promoter,tein levels increased in the first 2 hr after addition of
PMA and ionomycin and decreased at 4 hr (Figure 2C). In we generated polyclonal cell lines stably expressing
HDAC7 or HDAC7 mutants (H656A and H657A). Theparallel, acetylated histone H3 was immunoprecipitated
from chromatin solution, and the presence of Nur77 H657A mutation abolished enzymatic activity of HDAC7
while the H656A mutation had no effect, as expectedpromoter sequences was analyzed by PCR. This analy-
sis revealed that the Nur77 promoter became relatively based on our recent mutational analysis of HDAC4, a
closely related protein (Fischle et al., 2002). DO11.10enriched in acetylated histone H3 during the first 2 hr
after induction and returned to basal levels by 4 hr after cells were infected with a retrovirus expressing HDAC7
or HDAC7 mutants and green fluorescent protein (GFP)induction, in close parallel to the Nur77 protein (Figure 2C).
The transcriptional repression mediated by Class II from a polycistronic mRNA in which the two open read-
ing frames are separated by an internal ribosome entryHDACs is regulated, in part, via their nucleo-cytoplasmic
localization. To determine the subcellular localization of site. Transduced cells were sorted by flow cytometry
based on GFP expression and activated by treatmentHDAC7, we transfected DO11.10 cells with an HDAC7-
GFP fusion construct. Using real-time immunofluores- with PMA/ionomycin. Nur77 protein induction was
strongly inhibited by wild-type HDAC7 and by the cata-cence microscopy on live cells, we observed that unacti-
vated DO11.10 cells showed predominantly nuclear lytically active H656A mutant but not by the catalytically
inactive H657A mutant (Figure 3A).HDAC7 (Figure 2D). Fifteen minutes after addition of
PMA/ionomycin, HDAC7 was observed relocating to the Next, we examined the effect of HDAC7 on the tran-
scriptional activity of the isolated Nur77 promoter in acytoplasm. Exclusion of HDAC7 from the nucleus was
complete after 30 min, in agreement with the kinetics reporter assay (Woronicz et al., 1995). PMA/ionomycin
treatment increased the activity of the transfectedof Nur77 induction after PMA/ionomycin (Figure 2C).
These results indicate that Nur77 transcription is regu- Nur77-promoter construct by 100-fold (Figure 3B). Ex-
pression of HDAC7 inhibited Nur77 promoter activity inlated by acetylation and suggest that HDAC7 could be
involved in this mechanism. a dose-dependent manner (Figure 3B).
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mocytes, whereas the isotype control immunoprecipita-
tion showed no associated MEF2D protein (Figure 4C).
These results are consistent with the hypothesis that
HDAC7 is recruited to the Nur77 promoter through an
interaction with MEF2D.
Interaction of HDAC7 with MEF2D Is Essential
for Repression of Nur77
Both HDAC4 and HDAC5 interact with MEF2 proteins
via a conserved motif of 17 amino acids located in the
amino-terminal region of the proteins (Figure 5A). To
determine the possible function of this motif, we gener-
ated mutants of HDAC7 by deleting the entire 17 amino
acid stretch (Figure 5A, HDAC7-MEF) or by substitut-
ing several residues with alanine residues (HDAC7-
K86AK88A and HDAC7-Q87AE91A) (Figure 5A). HDAC7
and mutants were synthesized and labeled in vitro andFigure 4. HDAC7 and MEF2D Interact In Vivo
tested for their ability to interact with GST-MEF2D fusion(A) Total cellular extracts prepared from DO11.10 cell lines stably
protein in pull-down experiments. HDAC7 specificallyexpressing HDAC7 or its amino terminus were immunoprecipitated
interacted with GST-MEF2D but not with GST alonewith anti-FLAG antiserum and analyzed by Western blotting with an
antibody against MEF2D (MEF2D). The immunoprecipitated mate- (Figure 5B). In contrast, HDAC7-MEF and HDAC7-
rial was analyzed in parallel by Western blotting with an anti-FLAG K86AK88A did not interact with MEF2D, while the double
antiserum (FLAG). Input equals 10% of the lysate used in the immu- mutant HDAC7 Q87AE91A retained the capacity to inter-
noprecipitation.
act with MEF2D (Figure 5B). To confirm these observa-(B) Binding of MEF2D to the carboxyl (C-ter) or amino (N-ter) termi-
tions in vivo, we transduced FLAG-tagged versions ofnus of HDAC7 was measured in pull-down assays with in vitro trans-
these HDAC7 expression vectors into DO11.10 cells.lated 35S-labeled MEF2D. Input corresponds to 10% of the material
used for pull-down. After establishment of polyclonal cell lines, stably ex-
(C) Total cellular extracts from DO11.10 cells or primary thymocytes pressed proteins were immunoprecipitated with an anti-
were immunoprecipitated with an antiserum specific for HDAC7 or FLAG antibody and assessed for binding to endogenous
an isotype control. Immunoprecipitated material was analyzed by
MEF2D. In agreement with in vitro experiments, HDAC7Western blotting with an antiserum against MEF2D (-MEF2D).
and the HDAC7-Q87AE91A mutant interacted with en-
dogenous MEF2D while the HDAC7-MEF and HDAC7-
K86AK88A mutants showed no MEF2D binding (Fig-To demonstrate the specificity of Nur77 inhibition by
ure 5C).HDAC7, we examined two other markers of T cell activa-
To determine the functional role of the MEF2D-HDAC7tion, CD69 (early) and CD25 (late), in T cell hybridoma
interaction, we tested the HDAC7 mutants for their abilitytransduced with HDAC7 or the empty vector. Both CD69
to repress the Nur77 promoter. Expression of the HDAC7and CD25 were induced to the same degree in response
mutants defective for MEF2D binding (HDAC7-MEFto PMA/ionomycin, independently of HDAC7 expression
and HDAC7-K86AK88A) had no effect on Nur77 pro-(Figure 3C). As expected, induction of Nur77 was inhib-
moter activity in transfection assays (Figure 5D). In con-ited in the cell line expressing HDAC7 (Figure 3C, lower
trast, both wild-type HDAC7 and the HDAC7-Q87AE91Apanel). These results indicate that HDAC7 specifically
mutant inhibited transcriptional activation of the Nur77represses Nur77 transcription.
reporter (Figure 5D). Next, polyclonal cell lines stably
expressing each mutant were obtained after transduc-HDAC7 Interacts with MEF2D via Its Amino Terminus
tion of DO11.10 cells. In agreement with our transfectionClass II HDACs interact with members of the MEF2 fam-
experiments, HDAC7 mutants unable to interact withily via a small domain located in their amino terminus.
MEF2D (HDAC7-MEF and HDAC7-K86AK88A) failedTo determine whether HDAC7 interacts with MEF2D, we
to repress endogenous Nur77 expression (Figure 5E).generated stable polyclonal cell lines expressing FLAG-
These experiments demonstrate that the HDAC7-tagged HDAC7 or its amino-terminal domain (amino
MEF2D interaction is necessary for HDAC7 to repressacids 1–487). HDAC7 was immunoprecipitated with an
Nur77 transcription.anti-FLAG antibody, and the presence of endogenous
MEF2D was detected by Western blot analysis. Both
full-length HDAC7 and its amino-terminal domain specif- The Nur77 Promoter Is Transactivated by a Fusion
Protein Between HDAC7 and the VP16ically coimmunoprecipitated with endogenous MEF2D
(Figure 4A). Transactivating Domain
To further demonstrate the specific recruitment ofTo test whether this interaction was direct or indirect,
we expressed the N- (aa 1–488) and C-terminal (aa 438– HDAC7 to the Nur77 promoter, we fused the N terminus
of HDAC7 or of a mutant lacking the MEF2D interaction915) regions of HDAC7 as GST fusion proteins in E. coli
and tested their ability to interact with in vitro translated domain to the herpes simplex virus VP16 transactivation
domain (Nter-VP16 and NterMEF-VP16, Figure 6A).MEF2D. MEF2D bound to the N-terminal but not to the
C-terminal fragment of HDAC7 (Figure 4B). Both constructs were independently transfected in
DO11.10 cells with pRSRFwt-Luc, a reporter constructFinally, endogenous MEF2D coimmunoprecipitated
with HDAC7 in both T cell hybridomas and primary thy- containing four MEF2D DNA binding sites derived from
Immunity
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Figure 5. Interaction of HDAC7 with MEF2D
Is Necessary for Repression of Nur77 Ex-
pression
(A) Sequence comparison of the MEF2D bind-
ing domain of HDAC4, HDAC5, and HDAC7
(conserved residues are in black; semicon-
served residues in gray).
(B) Binding of HDAC7 and mutants to GST-
MEF2D was tested in a pull-down assay with
in vitro translated 35S-labeled MEF2D. The in-
put amount is equal to 10% of the material
used in the pull-down.
(C) HDAC7 and mutants were stably ex-
pressed in DO11.10 cells. Total cellular ly-
sates were immunoprecipitated with an anti-
FLAG antiserum and analyzed by Western
blot with specific antisera for MEF2D
(-MEF2D) and the FLAG epitope as control
(-FLAG). Input equals 10% of the lysate used
in the immunoprecipitation. The lower band
represents the light chain from mouse IgGs
used in the immunoprecipitation.
(D) D011.10 cells were cotransfected with
pNur77-Luc and the indicated HDAC7 ex-
pression vectors and activated with PMA/
ionomycin for 4 hr. Luciferase activity was
measured in treated () and untreated ()
cells. The results are from three independent
experiments each in triplicate. The activity of
the Nur77 promoter is expressed relative to
its activity after PMA/ionomycin treatment in
mock-transfected cells.
(E) Total cellular lysates were prepared from
polyclonal DO11.10 cells stably expressing
FLAG-tagged versions of wild-type HDAC7,
HDAC7-MEF, HDAC7-K86AK88A, HDAC7-
Q87AE91A, or pCDNA3.1 (Mock), treated with
PMA/ionomycin for 1.5 hr. Cell lysates were
analyzed by Western blotting with antisera
for Nur77, FLAG, and actin.
the Nur77 promoter (Figure 6B, gray bars). As a control, not affected by any of the constructs (Figure 6D, black
bars).a pRSRFmut-Luc construct containing mutated ME2D
binding sites was used (Figure 6B, black bars). Cotrans-
fection of pRSRFwt-Luc with Nter-VP16 yielded tran- A Phosphorylation Mutant HDAC7 Suppresses Nur77
Induction in Response to TCR Activationscriptional activation at levels similar to those obtained
with PMA/ionomycin. In contrast, the NterMEF-VP16 Phosphorylation of serine residues in the amino termi-
nus of class IIa HDACs is required for their nuclear exportprotein had no effect on pRSRFwt-Luc, indicating that
the interaction of MEF2D with the amino terminus of to the cytoplasm (Wang et al., 2000; Kao et al., 2001;
Zhang et al., 2001; Miska et al., 2001; McKinsey et al.,HDAC7 is critical. As expected, the pRSRFmut-Luc con-
struct was unaffected by all treatments (Figure 6B). 2000a, 2000b; Grozinger and Schreiber, 2000). Each of
these conserved serine residues was mutated to an ala-Next, we measured the expression of endogenous
Nur77 in cells transfected with Nter-VP16 using Northern nine individually (S155A, S318A, and S448A) or as a
combined triple mutant (P). Constructs containing ablot analysis. The Nur77 message was barely detectable
in cells transfected with the control vector and was single mutated serine (S155A, S318A, and S448A) inhib-
ited Nur77 transcriptional activity slightly better thanstrongly activated in response to PMA/ionomycin, as
previously reported (Figure 6C) (Woronicz et al., 1995). wild-type HDAC7 (Figure 7A). However, the triple mutant
(HDAC7-P) almost totally abolished induction of Nur77Transfection of the Nter-VP16 construct, but not Nter
MEF-VP16 or the empty vector (FLAG-VP16), activated transcription by PMA/ionomycin treatment.
To assess the subcellular localization of the tripleendogenous Nur77 expression (see Figure 6C). Similar
results were obtained by measuring the activity of a phosphorylation mutant, we transfected an HDAC7P-
GFP construct into DO11.10 cells (Figure 7B). In unstim-Nur77-dependent promoter (NBRE-Luc) after transfec-
tion (Figure 6D, gray bars). As expected, an NBRE-luc ulated cells, HDAC7P localized mainly in the nucleus,
similar to HDAC7. As expected, wild-type HDAC7 wasconstruct containing mutated Nur77 binding sites was
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Figure 6. Induction of Nur77 Expression by HDAC7-VP16 Fusion Proteins
(A) Schematic representation of wild-type (HDAC7) and modified versions of HDAC7, Nter-VP16, and NterMEF-VP16.
(B) Fusion constructs schematized in (A) were cotransfected in DO11.10 with pRSRF-Luc. Luciferase activities are shown relative to the
luciferase activity measured after 4 hr of treatment with PMA/ionomycin (100%). Gray bars correspond to the wild-type pRSRFwt-Luc and
dark bars to pRSRFmut-Luc.
(C) VP16-fusion constructs schematized in (A) were transfected in DO11.10, and Nur77 was detected by Northern blot. Hybridization with a
human GAPDH probe is shown as a control for equal RNA loading.
(D) Fusion constructs schematized in (A) were cotransfected in DO11.10 with pNBRE-Luc. Luciferase activities are shown relative to the
luciferase activity measured after 4 hr of treatment with PMA/ionomycin (100%). Gray bars correspond to the wild-type pNBREwt-Luc and
dark bars to pNBREmut-Luc.
exported out of the nucleus following stimulation with HDAC7 weakly inhibited apoptosis induced by PMA/
ionomycin or CD3 antibodies (Figure 8A, HDAC7). InPMA/ionomycin or -CD3 antibodies (Figure 7B). In con-
trast, HDAC7P remained nuclear in response to the contrast, overexpression of HDAC7P was associated
with significantly stronger inhibition of apoptosis (Figuresame treatments (Figure 7B).
Next, we assessed the ability of HDAC7P to repress 8A). Importantly, this protective effect was not observed
when cell death was induced by dexamethasone (datathe induction of endogenous Nur77. Cells treated with
PMA/ionomycin had elevated Nur77 expression which not shown).
Next, we predicted that suppression of HDAC7 ex-was weakly inhibited in cells transduced with HDAC7
and completely suppressed in response to HDAC7P pression should lead to an increase in apoptosis in re-
sponse to TCR activation. We used a murine stem cell(HDAC7P, Figure 7C). These observations were con-
firmed using a Nur77-dependent reporter construct virus (MSCV)-based retroviral vector to introduce a small
hairpin RNA (shRNA) specific for either HDAC7 or for(pNBRE-Luc). Despite being expressed at significantly
lower levels than HDAC7, HDAC7P led to complete GL3 luciferase in DO11.10 cells. Western blot analysis
of cells transduced with these vectors revealed that thesuppression of promoter activity while HDAC7 only led
to partial inhibition (Figure 7D). HDAC7-specific shRNA inhibited HDAC7 expression to
undetectable levels while the GL3 luciferase shRNA was
without effect (Figure 8B, right panel). In agreement withHDAC7 Modulates the Rate of Thymocyte Apoptosis
in Response to TCR Signaling our model, the cell line containing the HDAC7-specific
shRNA showed increased apoptosis in response toThese observations suggested that HDAC7 could regu-
late thymocyte apoptosis following TCR engagement. -CD3 antibody over a range of concentrations (Figure
8B, left panel). These observations demonstrate thatFirst, we tested whether overexpression of HDAC7P
inhibits TCR-mediated apoptosis. We used cells stably HDAC7 expression modulates the apoptosis rate of
T cells in response to T cell activation signals.transduced with HDAC7 or HDAC7P and measured
their apoptosis rate in response to PMA/ionomycin or
CD3 antibody (Figure 8A). High levels of apoptosis were Discussion
detected in the control cell line transduced with empty
vector following a 24 hr treatment with PMA/ionomycin We report here that HDAC7 represses Nur77 expression
and modulates the rate of apoptosis of T cells in re-or CD3 antibody (Figure 8A, Mock). Overexpression of
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Figure 7. Superrepression of Nur77 Expression by a Nuclear-Export-Defective HDAC7
(A) Schematic representation of HDAC7. The MEF2D interaction motif, the nuclear localization signal (NLS), the nuclear export signal (NES),
and the positions of phosphorylated serines are indicated. D011.10 cells were transfected with the pNur77-Luc reporter construct and the
same quantity of empty vector (Mock), wild-type HDAC7 (WT), or the indicated mutant (S155A, S318A, S448A, or P) expression vector, and
activated with PMA/ionomycin for 4 hr. Luciferase activity was measured in treated () and untreated () cells. The results are from three
independent experiments each in triplicate. The activity of the Nur77 promoter is expressed relative to its activity after PMA/ionomycin
treatment in mock-transfected cells.
(B) DO11.10 cells were transfected with HDAC7-GFP or HDAC7P-GFP. Cells were untreated or treated with PMA/ionomycin or CD3
antibodies 24 hr posttransfection. Intracellular localization of GFP-fusion proteins was monitored by immunofluorescence microscopy after
2 hr of treatment.
(C) Total cellular lysates were prepared from polyclonal DO11.10 cells stably expressing FLAG-tagged versions of wild-type HDAC7, HDAC7P,
or empty vector (Mock) and treated with PMA/ionomycin for 0, 1, 2, or 4 hr. Cell lysates were analyzed by Western blotting with antisera for
Nur77, HDAC7, and actin.
(D) Expression vectors for either wild-type HDAC7, HDAC7P, or empty vector (Mock) were cotransfected in DO11.10 with pNBREwt-Luc.
Luciferase activities were measured after 0, 2, 4, 6, and 8 hr in PMA/ionomycin-treated cells () or untreated cells () as control. Results are
presented relative to the luciferase activity measured after 8 hr of treatment in the mock-transfected cells (100%).
sponse to TCR engagement. Previous work identified As an alternative model, HDAC7 and Cabin-1 could
control Nur77 activation by TCR stimulation at discreteCabin-1, a MEF2D binding protein, as an inhibitor of
Nur77 expression and TCR-mediated apoptosis (Youn stages during thymocyte maturation, each repressor en-
suring the silencing of Nur77 expression at a distinctand Liu, 2000; Youn et al., 1999). However, deletion of
the MEF2D interacting domain of Cabin-1 did not affect developmental stage. While Cabin-1 is ubiquitously ex-
pressed, HDAC7 is predominantly expressed in double-T cell apoptosis in mice, an observation compatible with
the existence of redundant regulatory processes (Esau positive thymocytes, where negative selection via TCR
signaling occurs.et al., 2001).
Two distinct models can account for these observa- Independently of the repressor mechanism, previous
observations and data presented in this manuscript sup-tions. First, both Cabin-1 and HDAC7 could be coex-
pressed at the same stage in thymocyte development. port the model that the level of histone acetylation in
the Nur77 promoter is an important determinant of itsWhen present in the same cell, HDAC7 and Cabin-1
could be acting simultaneously to ensure a strict control transcriptional activity. MEF2D-associated Cabin-1 re-
presses Nur77 transcriptional activity partly by recruitingof Nur77 expression. These multiple repressors would
ensure that activation of Nur77 transcription happens HDAC1 and -2 via Sin3 (Youn and Liu, 2000). We ob-
served that HDAC7 is recruited to the Nur77 promoteronly when proper signaling cascades converge in the
nucleus of the developing thymocyte and inactivate both via its interaction with MEF2D and inhibits transcription
through its deacetylase activity. We provide direct ex-repressors. The expression of two distinct repressors
in the same cell may reflect the importance of avoiding perimental evidence that TCR activation of Nur77 tran-
scription is accompanied by local hyperacetylation ofinappropriate expression of the Nur77 death gene during
thymic development of T cells. histones. Furthermore, treatment of thymocytes with the
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Figure 8. HDAC7 Regulates Thymocyte Apo-
ptosis in Response to TCR Engagement
(A) Polyclonal DO11.10 cell lines, stably ex-
pressing HDAC7, HDAC7P, or the empty vec-
tor (Mock), were stimulated with PMA/iono-
mycin or CD3 antibodies. Apoptotic cells
were detected after 24 hr by phycoerythrin-
annexin V staining and flow cytometry analysis.
Flow histograms illustrate the percentages of
apoptotic cells detected in a representative
experiment. Bar histograms represent the
mean apoptotic rates from four independent
experiments and are expressed relative to the
apoptotic rate observed in the mock-trans-
duced cell line (100%).
(B) Polyclonal cell lines transduced with
shRNA for either HDAC7 or GL3 luciferase
were incubatd for 13 hr in wells precoated
with CD3  (Pharmingen, clone 500A2; 7,
15, 31, 62, 125, and 250 ng/ml) and CD28
(Pharmingen, clone 37.51, 1 g/ml) antibod-
ies and assayed for apoptosis. Results shown
are representative of three separate ex-
periments, each performed in triplicate. Dif-
ference in apoptosis between the two cell
populations are significant at antibody con-
centrations of 31, 62, and 125 ng/ml (p 
0.01).
histone deacetylase inhibitor TSA alone activates the dent on signals delivered by the activation of the TCR.
Cells that express a functional TCR undergo either posi-Nur77 promoter. This observation indicates that the
Nur77 promoter belongs to a small fraction of cellular tive or negative selection. Based on our observations,
we speculate that HDAC7 plays a critical role in de-promoters (2% or less) that are under the dominant
control of a repressive HDAC and can be activated solely termining the threshold level at which a developing T cell
undergoes positive versus negative selection. HDAC7by inhibition of HDAC activity (Van Lint et al., 1996).
According to current models of T cell maturation, thy- could allow some level of TCR activation without a con-
comitant increase in Nur77 expression, a situation thatmic negative and positive selections are directly depen-
Immunity
696
Cell viability was also confirmed by propidium iodide (PI) exclusionmight allow for positive selection to occur. When the
assay.TCR signal is sufficiently strong, the suppressive effect
of HDAC7 on Nur77 expression would be overwhelmed,
Flow Cytometry and RT-PCRresulting in Nur77 expression and negative selection via
Postnatal human thymus specimens were obtained from patients
apoptosis. According to this model, HDAC7 therefore undergoing cardiac surgery (Moffitt Hospital at University of Califor-
might serve as a rheostat modulating the apoptotic re- nia, San Francisco) and were processed within 6 hr. After mechani-
sponse of developing thymocytes in response to TCR cal disruption of thymus fragments, single-cell suspensions of thy-
mocytes were stained with a mAb cocktail containing CD4-PEactivation. Our observations that overexpression of
(Becton Dickinson), CD8-Tricolor (Becton Dickinson), and CD3-FITCHDAC7 inhibits apoptosis and that inhibition of HDAC7
(Becton Dickinson). A FACS Vantage (Becton Dickinson) was usedexpression via shRNA enhances apoptosis support this
to purify five thymocyte subsets: CD3CD4CD8 (SP4), CD3
model. Future experiments in transgenic mice will di- CD4CD8 (SP8), CD3lowCD4CD8 (DPlow), CD3med/highCD4CD8
rectly test this hypothesis and further define the role of (DPmed/high), and CD3CD4CD8 (TN). Typically, the purity of sorted
HDAC7 in thymic T cell selection. cells was greater than 97%. Thymocyte subpopulations were frozen
as dry pellets and stored at 80C for RNA extraction. Total RNA was
extracted from frozen pellets (105 cells) with Trizol (Gibco BRL)Experimental Procedures
according to the manufacturer’s instructions. RNA was treated with
DNaseI (RQ1 Rnase-Free Dnase, Promega) to ensure total removalPlasmids
of genomic DNA. First-strand cDNA (20 l) was generated fromThe pcDNA3.1-based expression vector for FLAG-tagged human
isolated RNA with the SuperScript First-Strand Synthesis SystemHDAC7 has been described elsewhere (Fischle et al., 2001a).
for RT-PCR (Gibco BRL) as described by the manufacturer. HDACC-terminal green fluorescence protein fusions were constructed in
mRNAs were quantified with the TaqMan fluorogenic detection sys-peGFP-N1 (Clontech). Deletion constructs of HDAC7 were gener-
tem on an ABI Prism 7700 Sequence Detector (Perkin-Elmer Appliedated by PCR and cloning procedures as described (Fischle et al.,
Biosystems). PCR reactions were performed in duplicate on two2001a). Site-directed mutagenesis was performed with the Quik-
dilutions of first strand cDNA with the following primers: HDAC4Change kit (Stratagene). All mutations were verified by DNA se-
forward 5	-TGACCGCCATTTGCGA-3	, HDAC4 reverse 5	-CGTTTCquencing. To construct N-terminal GST-fusion proteins, EcoRI frag-
CCAGCAAGGCA-3	, HDAC5 forward 5	-TGGTCTACGACACGTTments from the pcDNA3.1 expression constructs were subcloned
CATGCT-3	, HDAC5 reverse 5	-TCAGGGTGCACGTGTGTGTT-3	,into the EcoRI site of pGEX4T1 (Pharmacia). The luciferase reporter
HDAC7 forward 5	-TGGTGTCTGCTGGATTTGATG-3	, HDAC7 re-plasmid driven by the Nur77 promoter (pNur77-Luc) was generated
verse 5	-ATCCAAAACATTTGGCAGAAACAT-3	. MGB-5	-CCTCGGAby cloning the 3800 to 87 genomic sequences of the Nur77
AGCATGTGTTA-3	, MGB-5	-CACCAGTGCATGTGC-3	, and FAM-promoter (a kind gift from Astar Winoto, University of California,
5	-CCGGCCCCACTGGGTGGCTA-3	TAMRA (Operon, CA) wereBerkeley) (Woronicz et al., 1995) into pGL2 basic (Promega). Mouse
used as HDAC4, HDAC5, and HDAC7-specific probe, respectively.MEF2D was also received from Winoto’s lab. Minimal MEF2 wild-
PCR amplification consisted of denaturation at 95C for 10 min,type and mutant reporter constructs (pRSRFwt-Luc and pRSRFmut-
followed by 40 cycles of denaturation at 95C for 15 s and annealing/Luc) are described elsewhere (Woronicz et al., 1995).
extension at 58C for HDAC7 or 60C for HDAC4/5 for 60 s. For
GAPDH detection, the TaqMan GAPDH control reagents kit (Applied
Cell Culture, Transfections, and Reporter Assay Biosystems, CA) was used with an annealing/extension step at 60C.
DO11.10 T cell hybridomas were grown at 37C in RPMI 1640 me- Standard curves were plotted for HDACs and GAPDH. For each
dium supplemented with 10% fetal bovine serum, 2 mM glutamine, sample, HDAC expression was normalized to GAPDH.
and 50 U/ml streptomycin/penicillin. Transfections were performed For CD69 and CD25 expression studies, a polyclonal cell line
by the DEAE-dextran-chloroquine method. The DNA concentration overexpressing HDAC7 was stimulated with PMA/ionomycin. After
was kept constant in the different samples by using the correspond- 2 (CD69) and 8 hr (CD25) of treatment, cells were stained with the
ing empty vector. In some cases, cells were treated with PMA (10 corresponding PE-coupled monoclonal antibodies (Pharmingen)
ng/ml) and ionomycin (0.5M) for 4 hr, beginning 16 hr after transfec- and analyzed by flow cytometry using a FACScan cytometer (Beck-
tion, and harvested for reporter assays. All transfections were done ton Dickinson)
in triplicate and are presented as the result of at least three indepen-
dent experiments. Luciferase reporter assays were done with the Northern Blot Analysis
dual luciferase reporter assay system (Promega) using an EF1 The tissue expression of HDAC7 was analyzed with a multiple human
promoter-driven Renilla luciferase expression vector as an internal tissue Northern blot and RNA master blots from Clontech. For TSA
control. treatment, DO11.10 cells were treated with 400 nM TSA (Sigma) for
For all -CD3 stimulation (except in Figure 8C), monoclonal anti- various times. Total RNA (5 g) isolated with Trizol was used to
body 500A2 was bound to the culture flask by incubating a 1/50,000 detect the Nur77 message by standard Northern blot analysis (Sam-
dilution of raw ascites fluid in PBS overnight at 4C followed by brook et al., 1989). 32P-labeled probes corresponding to human
three rinses with PBS. HDAC7, mouse Nur77, or human GAPDH were prepared with the
Megaprime DNA labeling system (Amersham Pharmacia Biotech).
Blots were prehybridized and hybridized with ExpressHyb hybridiza-Polyclonal Cell Lines
tion solution (Clontech) and washed under high stringency condi-HDAC7 constructs were cloned into HIV-1 (provided by D. Trono,
tions (Sambrook et al., 1989). Autoradiographs were analyzed withUniversity of Geneva) or MSCV-based retroviral vectors (Hawley et
a FUJIX BAS1000 phosphor imaging system (Fuji, Tokyo, Japan).al., 1994). These vectors allow simultaneous expression of HDAC7
and eGFP by using an internal ribosome entry site. Production of
HIV-derived particles was performed as described (Jordan et al., In Situ Hybridization
In situ hybridization was performed according to Mannheim (1996).2001). MSCV recombinant retroviruses were obtained by transfec-
tion of retroviral vector plasmids into ecotropic virus-packaging cells Sense and antisense digoxigenin-labeled human HDAC7 riboprobes
were prepared with the Dig RNA Labeling Kit (Boehringer Mannheim)(BOSC23) (Pear et al., 1993). DO11.10 cells (0.5 
 106 ) were spin
infected for 2 hr at 2400 rpm in 2 ml of viral stock containing poly- and shortened to 150–300 base fragments by alkaline hydrolysis.
Sections of formalin-fixed paraffin-embedded tissue (4 m thick)brene at 4g/ml (Pear et al., 1993). The cells were allowed to recover
for 24–48 hr, and GFP-expressing cells (30%) were sorted by flow were deparaffinized, hydrated, pretreated with 0.2N HCl for 10 min
and digested with proteinase K (Dako) for 25 min. The tissue wascytometry and expanded for further analysis. The percentage of
GFP-positive cells was stable over time and typically above 98%. covered with probe solution (0.5 ng/l) and hybridized overnight at
55C. Excess probe was removed by stringent washes with: 5
 SSCFor cell death assay, phycoerythrin (PE)-coupled annexin V (Phar-
mingen) was used following the manufacturer’s recommendations. for 30 min at 37C, 50% formamide/50% 2
 SSC for 20 min at 55C,
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2
 SSC for 15 min at 42C, and 0.1
 SSC for 15 min at 42C. gel and detected with a FUJIX BAS1000 phosphor imaging system
(Fuji, Tokyo, Japan).The sections were incubated with anti-digoxigenin Fab fragments
conjugated with alkaline phosphatase diluted 1:300 (Boehringer
Mannheim) for 30 min, followed by the substrate BCIP/NBT (Vector Generation of HDAC7-Deficient DO11.10 Cells
Laboratories, Burlingame, CA) and developed overnight. The slides MSCV-H1-GFP was constructed by inserting a human H1 promoter-
were washed and then counterstained with Nuclear Fast Red (Vector terminator cassette into MSCV Puro (Clontech) and replacing the
Laboratories). puromycin resistance gene with GFP. Sequences encoding shRNAs
targeted to either mouse HDAC7 (target sequence: AGACAAGAG
CAAGCGAAGt) or GL3 luciferase (target sequence: CTTACGCTImmunoprecipitation
GAGTACTTCGA) were ligated into MSCV H1 GFP to generate MSCV-Total cellular extracts from DO11.10 cells or primary thymocytes
H1-GFP/HDAC7 and MSCV-H1-GFP/GL3. DO11.10 cells were spinwere prepared in IPLS buffer (Fischle et al., 1999) supplemented
infected for 2 hr with MSCV-H1-GFP/HDAC7 or MSCV-H1-GFP/GL3with protease inhibitors (Complete, Roche Molecular Biochemicals,
three times at 24 hr intervals. Twenty-four hours after the last infec-IN). Immunoprecipitations were carried out overnight at 4C. For
tion (80% cells GFP-positive), cells exhibiting highest GFP fluores-FLAG-tagged proteins, M2-agarose (Sigma) antibody was used at 15
cence, 10% of the total cell population, were isolated by FACS.l/ml. For immunoprecipitation of endogenous HDAC7, anti-HDAC7
Cells were expanded and characterized as described in the text.antiserum was used at approximately 10 g/ml in combination with
20 /ml preblocked (10 mg/ml bovine serum albumin) 50% protein
G-Sepharose slurry (Amersham Pharmacia Biotech). Immunopre- Acknowledgments
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